citalopram has been researched along with Dyslipidemia in 1 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colotto, M | 1 |
| Vinci, F | 1 |
| Vo Hong, N | 1 |
| Raimo, O | 1 |
| Castello, A | 1 |
| Carnovale, A | 1 |
| Paciaroni, A | 1 |
| Coletta, P | 1 |
1 review available for citalopram and Dyslipidemia
| Article | Year |
|---|---|
[Effect of treatment with selective serotonin reuptake inhibitors on lipid profile: state of the art].
Topics: Antidepressive Agents; Citalopram; Depression; Depressive Disorder; Double-Blind Method; Dyslipidemi | 2012 |